Browsing by Author Kwok, GGW

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 7 of 7
TitleAuthor(s)Issue Date
 
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
Journal:Journal for ImmunoTherapy of Cancer
Wong, JSLKwok, GGWTang, VLi, BCWLeung, RChiu, JMa, KWShe, WHTsang, JLo, CMCheung, TTYau, T
2021
 
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib
Journal:Expert Review of Gastroenterology and Hepatology
Tsang, JWong, JSLKwok, GGWLi, BCWLeung, RChiu, JCheung, TTYau, T
2021
 
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
Journal:Cancers
Dong, YWong, JSLSugimura, RLam, KOLi, BKwok, GGWLeung, RChiu, JWYCheung, TTYan, T
2021
 
The outcomes of systemic treatment in recurrent hepatocellular carcinomas following liver transplants
Journal:Advances in Therapy
Li, BCWChiu, JShing, KKwok, GGWTang, VLeung, RMa, KWShe, WHTsang, JChan, ACheung, TTLo, CMYau, T
2021
 
The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study
Journal:Cancers
Wong, JSLDong, YTang, VLeung, TYeung, CSYTai, ALaw, AShum, TKwok, GGWLi, BCWLeung, RChiu, JMa, KWShe, WHTsang, JCheung, TTYau, T
2021
 
Thyroid Immune-Related Adverse Events Among Cancer Patients Treated With Combination of Anti-PD1 and Anti-CTLA4 Immune-Checkpoint Inhibitors: Clinical Course and Outcomes
Proceeding/Conference:Journal of the Endocrine Society
Lui, TWDLee, CHPTang, VFong, CHYLee, ACHChiu, JWYLeung, RCYKwok, GGWLi, BCHCheung, TTWoo, YCLam, KSLYau, TCC
2021
 
Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes
Journal:Endocrine Practice
Lui, DTWLee, CHTang, VFong, CHYLee, ACHChiu, JWYLeung, RCYKwok, GGWLi, BCWCheung, TTWoo, YCLam, KSLYau, T
2021
Showing results 1 to 7 of 7